Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Identifying patients with a history of ovarian cancer for referral for genetic counselling: non-randomised comparison of two case-finding strategies in primary care.

Helsper CW, Van Vliet LM, Velthuizen ME, de Wit NJ, Beijaert RP, Butter E, van Gent-Wagemakers MP, Witteveen EO, Zweemer RP, van Dulmen SM, Ausems MG.

Br J Gen Pract. 2018 Nov;68(676):e750-e756. doi: 10.3399/bjgp18X699533.

2.

Routine primary care data for scientific research, quality of care programs and educational purposes: the Julius General Practitioners' Network (JGPN).

Smeets HM, Kortekaas MF, Rutten FH, Bots ML, van der Kraan W, Daggelders G, Smits-Pelser H, Helsper CW, Hoes AW, de Wit NJ.

BMC Health Serv Res. 2018 Sep 25;18(1):735. doi: 10.1186/s12913-018-3528-5.

3.
4.

Effectiveness and cost-effectiveness of nationwide campaigns for awareness and case finding of hepatitis C targeted at people who inject drugs and the general population in the Netherlands.

Helsper CW, Janssen MP, van Essen GA, Croes EA, van der Veen C, de Wit AG, de Wit NJ.

Int J Drug Policy. 2017 Sep;47:117-125. doi: 10.1016/j.drugpo.2017.07.022. Epub 2017 Aug 18.

5.

Primary care management of women with breast cancer-related concerns-a dynamic cohort study using a network database.

Sollie A, Helsper CW, Ader RJ, Ausems MG, van der Wouden JC, Numans ME.

Eur J Cancer Care (Engl). 2016 Nov;25(6):1005-1014. doi: 10.1111/ecc.12526. Epub 2016 Jun 15.

PMID:
27302697
6.

Do GPs know their patients with cancer? Assessing the quality of cancer registration in Dutch primary care: a cross-sectional validation study.

Sollie A, Roskam J, Sijmons RH, Numans ME, Helsper CW.

BMJ Open. 2016 Sep 15;6(9):e012669. doi: 10.1136/bmjopen-2016-012669.

7.

Identification of patients at risk for colorectal cancer in primary care: an explorative study with routine healthcare data.

Koning NR, Moons LM, Büchner FL, Helsper CW, Ten Teije A, Numans ME.

Eur J Gastroenterol Hepatol. 2015 Dec;27(12):1443-8. doi: 10.1097/MEG.0000000000000472.

PMID:
26398457
8.

Outcomes of hepatitis C screening programs targeted at risk groups hidden in the general population: a systematic review.

Zuure FR, Urbanus AT, Langendam MW, Helsper CW, van den Berg CH, Davidovich U, Prins M.

BMC Public Health. 2014 Jan 22;14:66. doi: 10.1186/1471-2458-14-66. Review.

9.

Real-life costs of hepatitis C treatment.

Helsper CW, Hellinga HL, van Essen GA, de Wit GA, Bonten MJ, van Erpecum KJ, Hoepelman AI, Richter C, de Wit NJ.

Neth J Med. 2012 Apr;70(3):145-53.

10.

Cost-effectiveness of targeted screening for hepatitis C in The Netherlands.

Helsper CW, Borkent-Raven BA, de Wit NJ, van Essen GA, Bonten MJ, Hoepelman AI, Janssen MP, de Wit GA.

Epidemiol Infect. 2012 Jan;140(1):58-69. doi: 10.1017/S0950268811000112. Epub 2011 Feb 16.

PMID:
21324216
11.

A support programme for primary care leads to substantial improvements in the effectiveness of a public hepatitis C campaign.

Helsper CW, van Essen GA, Bonten MJ, de Wit NJ.

Fam Pract. 2010 Jun;27(3):328-32. doi: 10.1093/fampra/cmq006. Epub 2010 Mar 11.

PMID:
20223833
12.

Trends and determinants of adequate gastroprotection in patients chronically using NSAIDs.

Helsper CW, Smeets HM, Numans ME, Knol MJ, Hoes AW, de Wit NJ.

Pharmacoepidemiol Drug Saf. 2009 Sep;18(9):800-6. doi: 10.1002/pds.1783.

PMID:
19572313

Supplemental Content

Loading ...
Support Center